Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SENATE LABOR CMTE. HEALTH REFORM BILL WOULD REQUIRE HIGHER Rx DRUG COPAY

Executive Summary

SENATE LABOR CMTE. HEALTH REFORM BILL WOULD REQUIRE HIGHER Rx DRUG COPAY than is proposed under President Clinton's Health Security Act for those who select the lower-cost, HMO-type coverage option. The chairman's mark released by Labor Committee Chairman Kennedy (D-Mass.) May 11 would require a $10 copay per prescription, rather than the $5 copay proposed in the Clinton plan. The Kennedy mark does not amend the 20% prescription copay requirement that would apply to those enrolled in higher cost- sharing plans under the Health Security Act.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel